[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Status:
Completed
Trial end date:
2016-03-02
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to compare the effect of 90-day treatment with
ticagrelor (180 mg [two 90 mg tablets] loading dose on Day 1 followed by 90 mg twice daily
maintenance dose for the remainder of the study) vs acetylsalicylic acid (ASA)-aspirin (300
mg [three 100 mg tablets] loading dose on Day 1 followed by 100 mg once daily maintenance
dose for the remainder of the study) for the prevention of major vascular events (composite
of stroke, myocardial infarction [MI], and death) in patients with acute ischaemic stroke or
transient ischaemic attack (TIA).